Literature DB >> 2079838

Increased plasma pyridoxal-5'-phosphate levels before and after pyridoxine loading in carriers of perinatal/infantile hypophosphatasia.

B N Chodirker1, S P Coburn, L E Seargeant, M P Whyte, C R Greenberg.   

Abstract

We measured plasma levels of pyridoxal-5'-phosphate (PLP), a cofactor form of vitamin B6 and apparent natural substrate for alkaline phosphatase (ALP), in carriers and in non-carriers of the severe perinatal and infantile forms of hypophosphatasia, both before and after an oral load of pyridoxine (i.e. 1/3 mg/kg body weight). The assignment of carrier status was determined by serum ALP activity, level of serum inorganic phosphate, and if necessary urinary phosphoethanolamine excretion. Plasma PLP levels were significantly increased in the carriers both before and especially after B6 loading.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079838     DOI: 10.1007/BF01800216

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  Hypophosphatasia.

Authors:  D FRASER
Journal:  Am J Med       Date:  1957-05       Impact factor: 4.965

2.  Alkaline phosphatase is an ectoenzyme that acts on micromolar concentrations of natural substrates at physiologic pH in human osteosarcoma (SAOS-2) cells.

Authors:  K N Fedde; C C Lane; M P Whyte
Journal:  Arch Biochem Biophys       Date:  1988-08-01       Impact factor: 4.013

3.  Phosphorylethanolamine and hypophosphatasia.

Authors:  K Rasmussen
Journal:  Dan Med Bull       Date:  1968-09

4.  Hypophosphatasia.

Authors:  R I Macpherson; M Kroeker; C S Houston
Journal:  J Can Assoc Radiol       Date:  1972-03

5.  A versatile cation-exchange procedure of measuring the seven major forms of vitamin B6 in biological samples.

Authors:  S P Coburn; J D Mahuren
Journal:  Anal Biochem       Date:  1983-03       Impact factor: 3.365

6.  Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5'-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase.

Authors:  M P Whyte; J D Mahuren; K N Fedde; F S Cole; E R McCabe; S P Coburn
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

7.  Infantile hypophosphatasia: autosomal recessive transmission to two related sibships.

Authors:  C A Moore; J C Ward; M L Rivas; H L Magill; M P Whyte
Journal:  Am J Med Genet       Date:  1990-05

8.  Hyperphosphatemia in infantile hypophosphatasia: implications for carrier diagnosis and screening.

Authors:  B N Chodirker; J A Evans; L E Seargeant; M S Cheang; C R Greenberg
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

Review 9.  Vitamin B6: an overview.

Authors:  C E Shideler
Journal:  Am J Med Technol       Date:  1983-01
  9 in total
  9 in total

1.  Computer assisted analysis of hand radiographs in infantile hypophosphatasia carriers.

Authors:  B N Chodirker; D Roy; C R Greenberg; M Cheang; J A Evans; M H Reed
Journal:  Pediatr Radiol       Date:  1991

2.  ALPL mutations in adults with rheumatologic disorders and low serum alkaline phosphatase activity.

Authors:  Frank Rauch; Ghalib Bardai; Cheryl Rockman-Greenberg
Journal:  J Bone Miner Metab       Date:  2019-02-04       Impact factor: 2.626

3.  Hypophosphatasia - pathophysiology and treatment.

Authors:  José Luis Millán; Horacio Plotkin
Journal:  Actual osteol       Date:  2012-09-01

Review 4.  [Hypophosphatasia : What is currently available for treatment?]

Authors:  T Schmidt; M Amling; F Barvencik
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

Review 5.  Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.

Authors:  Michael P Whyte
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

6.  Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5'-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy.

Authors:  M P Whyte; M Landt; L M Ryan; R A Mulivor; P S Henthorn; K N Fedde; J D Mahuren; S P Coburn
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase.

Authors:  Kellen C S Gasque; Brian L Foster; Pia Kuss; Manisha C Yadav; Jin Liu; Tina Kiffer-Moreira; Andrea van Elsas; Nan Hatch; Martha J Somerman; José Luis Millán
Journal:  Bone       Date:  2014-11-26       Impact factor: 4.398

Review 8.  Alkaline Phosphatase and Hypophosphatasia.

Authors:  José Luis Millán; Michael P Whyte
Journal:  Calcif Tissue Int       Date:  2015-11-21       Impact factor: 4.333

9.  Clinical, biochemical and genetic findings in adult patients with chronic hypophosphatasemia.

Authors:  V Guarnieri; F Sileri; R Indirli; G Guabello; M Longhi; G Dito; C Verdelli; S Corbetta
Journal:  J Endocrinol Invest       Date:  2021-07-02       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.